000 | 01845 a2200565 4500 | ||
---|---|---|---|
005 | 20250513093913.0 | ||
264 | 0 | _c19961107 | |
008 | 199611s 0 0 eng d | ||
022 | _a0364-3190 | ||
024 | 7 |
_a10.1007/BF02527756 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSmith, C P | |
245 | 0 | 0 |
_aSerotonergic activity of HP 184: does spontaneous release have a role? _h[electronic resource] |
260 |
_bNeurochemical research _cMay 1996 |
||
300 |
_a575-83 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_a5-Hydroxytryptophan _xtoxicity |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBiogenic Amines _xmetabolism |
650 | 0 | 4 |
_aBlepharoptosis _xchemically induced |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aDrinking Behavior _xdrug effects |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aFenfluramine _xpharmacology |
650 | 0 | 4 |
_aHippocampus _xdrug effects |
650 | 0 | 4 |
_aHydroxyindoleacetic Acid _xmetabolism |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aIndoles _xpharmacokinetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNorepinephrine _xmetabolism |
650 | 0 | 4 |
_aPyridines _xpharmacokinetics |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aReceptors, Serotonin _xmetabolism |
650 | 0 | 4 | _aReceptors, Serotonin, 5-HT1 |
650 | 0 | 4 |
_aSerotonin _xmetabolism |
650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xpharmacokinetics |
650 | 0 | 4 |
_aSynaptosomes _xdrug effects |
650 | 0 | 4 | _aTetrabenazine |
700 | 1 | _aWoods-Kettelberger, A T | |
700 | 1 | _aCorbett, R | |
700 | 1 | _aChesson, S M | |
700 | 1 | _aBores, G M | |
700 | 1 | _aPetko, W W | |
700 | 1 | _aRoehr, J E | |
700 | 1 | _aKongsamut, S | |
773 | 0 |
_tNeurochemical research _gvol. 21 _gno. 5 _gp. 575-83 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02527756 _zAvailable from publisher's website |
999 |
_c8724104 _d8724104 |